| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/31/2013 | WO2013015545A1 Composition for edible film and pharmaceutical preparation for edible film containing drugs |
| 01/31/2013 | WO2013015419A1 Blood container for use in centrifuge |
| 01/31/2013 | WO2013014452A1 Supramolecular capsules |
| 01/31/2013 | WO2013014196A1 Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein |
| 01/31/2013 | WO2013014149A1 Il-12 immunoconjugate |
| 01/31/2013 | WO2013013603A1 Livestock intestinal sustained-release anthelmintic and preparation method therefor |
| 01/31/2013 | WO2012172433A3 A sustained -release composition containing a melanocortin receptor ligand as the active ingredient |
| 01/31/2013 | WO2012168431A3 Polypeptides |
| 01/31/2013 | WO2012168430A3 Polypeptides |
| 01/31/2013 | WO2012159052A3 Targeted delivery of proteins across the blood brain barrier |
| 01/31/2013 | WO2012149301A3 Tolerogenic synthetic nanocarriers for inducing regulatory b cells |
| 01/31/2013 | WO2012136816A3 Pharmaceutical composition |
| 01/31/2013 | WO2012135630A3 Crk-a novel target for cancer therapy |
| 01/31/2013 | WO2012135562A3 Polymer conjugates targeting cells and methods related thereto |
| 01/31/2013 | WO2012116210A3 Peptide for the induction of immune tolerance as treatment for systemic lupus erythematosus |
| 01/31/2013 | WO2012094653A4 Compositions and methods for macromolecular drug delivery |
| 01/31/2013 | WO2011159871A8 Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease |
| 01/31/2013 | US20130030282 Synthesis and characterization of near ir fluorescent magnetic and non-magnetic albumin nanoparticles for biomedical applications |
| 01/31/2013 | US20130030061 Functionalized amino acids and absorbable polymers therefrom |
| 01/31/2013 | US20130030060 Glucosyl Stevia Composition |
| 01/31/2013 | US20130030059 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 01/31/2013 | US20130030058 Kit and method for producing bone cement |
| 01/31/2013 | US20130030030 Allantoin-containing skin cream |
| 01/31/2013 | US20130029965 Pharmaceutical solid dispersions |
| 01/31/2013 | US20130029936 Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same |
| 01/31/2013 | US20130029932 Composition for external use on skin, cosmetic, and cleaning agent |
| 01/31/2013 | US20130029913 Artificial platelets |
| 01/31/2013 | US20130028967 Therapeutic agent for pulmonary fibrosis |
| 01/31/2013 | US20130028955 Sustained release oral matrix and methods of making thereof |
| 01/31/2013 | US20130028934 Stabilizer and Vaccine Composition Comprising One or More Live Attenuated Flaviviruses |
| 01/31/2013 | US20130028846 Flavour Modulating Derivative of a Carboxylic Acid and a Purine, Pyrimidine, Nucleoside, or Nucleotide |
| 01/31/2013 | CA2843267A1 Two part formulation system for ophthalmic delivery |
| 01/31/2013 | CA2842695A1 Templated islet cells and small islet cell clusters for diabetes treatment |
| 01/31/2013 | CA2842053A1 Il-12 immunoconjugate |
| 01/31/2013 | CA2840727A1 Compositions and methods for the treatment of ocular surface allergies |
| 01/31/2013 | CA2838481A1 Matrix compositions for controlled release of peptide and polypeptide molecules |
| 01/31/2013 | CA2837732A1 Methylphenidate-prodrugs, processes of making and using the same |
| 01/30/2013 | EP2550975A1 Combination therapy for the treatment of CD19+ B-cell malignancies symptoms comprising an anti-CD19 maytansinoid immunoconjugate and rituximab |
| 01/30/2013 | EP2550962A2 Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof |
| 01/30/2013 | EP2550961A1 Solid preparation |
| 01/30/2013 | EP2550958A1 Controlled release formulations of lipocalin muteins |
| 01/30/2013 | EP2550037A1 Pharmaceutical composition containing cyclodextrin copolymer |
| 01/30/2013 | EP2550020A2 Reverse micelle microemulsion comprising metal ions and use thereof |
| 01/30/2013 | EP2550019A2 Temperature sensitive conjugate compositions, and uses related thereto |
| 01/30/2013 | EP2550018A1 Compositions and methods useful for stabilizing protein-containing formulations |
| 01/30/2013 | EP2550005A1 Transdermal administration of peptides |
| 01/30/2013 | EP2550004A1 Heparan sulfate replacement therapy |
| 01/30/2013 | EP2549998A1 Pharmaceutical composition comprising a pyrimidineone derivative |
| 01/30/2013 | EP2549993A2 Antimicrobial compositions |
| 01/30/2013 | CN1977166B Detection of methamphetamine class of drugs |
| 01/30/2013 | CN102906157A Derivatized hyperbranched polyglycerols |
| 01/30/2013 | CN102906127A Self-assembled particles from zwitterionic polymers and related methods |
| 01/30/2013 | CN102905763A Lipids, lipid compositions, and methods of using them |
| 01/30/2013 | CN102905762A Methods and compositions for inducing satiety |
| 01/30/2013 | CN102905730A Zwitterionic polymer bioconjugates and related methods |
| 01/30/2013 | CN102905729A Dose selection of adjuvanted synthetic nanocarriers |
| 01/30/2013 | CN102905728A Nanocarrier compositions with uncoupled adjuvant |
| 01/30/2013 | CN102905722A Long-acting Y2 receptor agonists |
| 01/30/2013 | CN102905717A Composition for transnasal administration and method for producing same |
| 01/30/2013 | CN102905707A Pharmaceutical preparation comprising phenylalanine derivative |
| 01/30/2013 | CN102905706A Pharmaceutical composition containing solifenacin |
| 01/30/2013 | CN102905695A Preparations of biologically active substances with enlarged surface area based on amphiphilic copolymers |
| 01/30/2013 | CN102905692A Stable multi-dose compositions comprising antibody and preservative |
| 01/30/2013 | CN102905672A Miniature ingestible device |
| 01/30/2013 | CN102898861A Preparation method of special sugar solution |
| 01/30/2013 | CN102898661A Polyethylene glycol hydrogel for orthotopic injection and preparation method thereof |
| 01/30/2013 | CN102898656A Method for preparing a chitosan / aliphatic polyester amphiphilic graft copolymer |
| 01/30/2013 | CN102898641A Single active functional group-containing Y-type polyethylene glycol and preparation method thereof |
| 01/30/2013 | CN102898543A Water-soluble carbon nanotube and application thereof |
| 01/30/2013 | CN102898542A Water-soluble fullerene and application thereof |
| 01/30/2013 | CN102898527A Pharmaceutical composition for preventing or treating cancer |
| 01/30/2013 | CN102898526A Tumor necrosis factor-related apoptosis-inducing ligand fusion protein, its preparation and application |
| 01/30/2013 | CN102898523A N-substituted-tetrahydropyridylindole-monoclonal antibody CD14 conjugates, and preparation method and application thereof |
| 01/30/2013 | CN102898522A Tetrahydropyridinopyran-monoclonal antibody CD14 conjugate with anti-tumor activity and preparation method and use thereof |
| 01/30/2013 | CN102895674A Preparation method of chitosan-5'ppp-NS1shRNA nanocomposite |
| 01/30/2013 | CN102895670A Water-soluble molecular target porphin photosensitizer and preparation method thereof |
| 01/30/2013 | CN102895669A Cis-platinum complex and preparation method thereof |
| 01/30/2013 | CN102895668A Method of delivering a protein into a cell |
| 01/30/2013 | CN102895667A Method for preparing lactobionic acid-crosslinked hepatic cell targeted viral vector |
| 01/30/2013 | CN102895666A Pegylated small molecules |
| 01/30/2013 | CN102895665A Preparation method of targeting graphene nano-grade drug carrier |
| 01/30/2013 | CN102895664A Gadolinium stabilizing amorphous calcium carbonate nanocomposite material and preparation method |
| 01/30/2013 | CN102895662A Composition for chemoembolotherapy of solid tumors |
| 01/30/2013 | CN102895656A Adenosine triphosphate-coenzyme-insulin compound-containing pharmaceutical composition |
| 01/30/2013 | CN102895655A Application of haemopoietin microspheres in preparation of medicaments for treating parkinsonism |
| 01/30/2013 | CN102895585A Preparation method of drug-fructus jujubae for treating edema disease |
| 01/30/2013 | CN102895416A Acupoint application preparation for treating flatulence |
| 01/30/2013 | CN102895277A Quality control method for chrysanthemum indicum alabastrum essential oil clathrate |
| 01/30/2013 | CN102895271A Emulsified dressing for treating endometriosis |
| 01/30/2013 | CN102895264A Red nocardia rubra cell wall skeleton buccal tablet and preparation method thereof |
| 01/30/2013 | CN102895259A Adenosine disodium triphosphate magnesium chloride compound-containing pharmaceutical composition |
| 01/30/2013 | CN102895255A Pharmaceutical composition of adenine arabinoside monophosphate and preparation method for pharmaceutical composition |
| 01/30/2013 | CN102895223A Dehydroandrographolide succinate compound-containing medicinal composition and its preparation method |
| 01/30/2013 | CN102895217A Long-acting donepezil percutaneous absorption sticking agent |
| 01/30/2013 | CN102895216A Anti-cancer medicament silicon plastid microcapsule and preparation method thereof |
| 01/30/2013 | CN102895213A Stable cefotiam hexetil hydrochloride composition |
| 01/30/2013 | CN102895212A Dry pressed coating tablet containing tegafur, gimeracil and oteracil potassium |
| 01/30/2013 | CN102895211A Sudden death and hypertension resistant metoprolol intelligent medicine release system and its preparation method |
| 01/30/2013 | CN102895210A Febuxostat tablet with improved dissolution rate |
| 01/30/2013 | CN102895209A Febuxostat tablet |